丸美生物(603983.SH)：向香港联交所递交H股发行上市的申请并刊发申请资料

Core Viewpoint - Marubi Biotechnology (603983.SH) has submitted an application for the issuance of H-shares and listing on the Hong Kong Stock Exchange on December 11, 2025 [1] Group 1 - The company has officially filed its application with the Hong Kong Stock Exchange [1] - The application materials for the issuance and listing have been published on the Hong Kong Stock Exchange's website [1]